Vistagen (VTGN): Long-term Game-changer
Actualizado
*This is not financial advice. This is my non-expert opinion.*
Vistagen (
VTGN) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (novavax.com/our-pipeline (
NVAX). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated.
Vistagen: https://www.vistagen.com/about
Pipeline: https://www.vistagen.com/pipeline
PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me https://www.youtube.com/watch?v=YC4pnAySd80
Keep an eye out for this company.
Vistagen (
VTGN) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (novavax.com/our-pipeline (NVAX). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated.Vistagen: https://www.vistagen.com/about
Pipeline: https://www.vistagen.com/pipeline
PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me https://www.youtube.com/watch?v=YC4pnAySd80
Keep an eye out for this company.
Nota
To clarify, the above earnings date is ESTIMATED.Source: marketbeat.com/stocks/NASDAQ/VTGN/earnings/
Publicaciones relacionadas
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.